Pacira BioSciences Inc. (PCRX)
25.31
0.89 (3.64%)
At close: Mar 27, 2025, 3:59 PM
25.02
-1.14%
Pre-market: Mar 28, 2025, 07:12 AM EDT
Pacira BioSciences Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 700.97M | 674.98M | 666.82M | 541.53M | 420.83M | 421.03M | 337.28M | 286.63M | 276.37M | 249M | 197.67M | 85.55M | 39.08M | 15.69M | 14.56M | 15.01M | 13.93M |
| Cost of Revenue | n/a | 184.67M | 199.29M | 140.25M | 117.33M | 106.71M | 86.84M | 87.92M | 110.1M | 71.84M | 77.44M | 54.77M | 32.14M | 16.74M | 12.28M | 12.3M | 17.46M |
| Gross Profit | 700.97M | 490.31M | 467.53M | 401.28M | 303.5M | 314.31M | 250.43M | 198.72M | 166.27M | 177.16M | 120.23M | 30.78M | 6.95M | -1.05M | 2.29M | 2.71M | -3.54M |
| Operating Income | -73.37M | 87.67M | 60.02M | 131.06M | 46.35M | 38.11M | 15.91M | -24.94M | -32.02M | 9.46M | -5.17M | -53.29M | -49.3M | -39.1M | -22.37M | -28.55M | -45.36M |
| Interest Income | 19.69M | 11.44M | 4.54M | 896K | 4.63M | 7.38M | 6.5M | 4.08M | 1.32M | 678K | 382K | 259K | 275K | 255K | 146K | 77K | 235K |
| Pretax Income | -63.11M | 61.7M | 13.3M | 56.4M | 20.09M | -10.75M | -425K | -42.47M | -37.84M | 2.12M | -13.54M | -64.35M | -52.28M | -43.33M | -27.15M | -28.18M | -45.59M |
| Net Income | -99.56M | 41.95M | 15.91M | 41.98M | 145.52M | -11.02M | -471K | -42.61M | -37.95M | 1.86M | -13.72M | -63.91M | -52.28M | -43.33M | -27.15M | -31.71M | -41.86M |
| Selling & General & Admin | 294.1M | 269.44M | 254.52M | 199.34M | 193.52M | 200.78M | 177.26M | 161.49M | 152.61M | 139.04M | 106.66M | 62.51M | 46.31M | 20.16M | 6.03M | 5.02M | 8.61M |
| Research & Development | 81.58M | 76.26M | 84.8M | 55.55M | 59.42M | 72.12M | 55.69M | 57.29M | 45.68M | 28.66M | 18.73M | 21.56M | 9.94M | 14.87M | 18.63M | 26.23M | 33.21M |
| Other Expenses | 398.66M | 56.94M | 57.29M | 13.55M | 7.87M | 5.7M | -888K | 167K | -82K | -165K | -159K | -47K | -111K | 3.02M | 6.03M | 5.02M | 8.61M |
| Operating Expenses | 774.34M | 402.63M | 396.6M | 268.44M | 260.8M | 278.6M | 232.95M | 218.78M | 198.29M | 167.71M | 125.39M | 84.07M | 56.24M | 35.03M | 24.66M | 31.25M | 41.83M |
| Interest Expense | 13.44M | 20.31M | 39.98M | 31.75M | 25.67M | 23.63M | 21.95M | 18.05M | 7.06M | 7.72M | 8.28M | 7.25M | 1.81M | 4.78M | 4.89M | 3.6M | 3.49M |
| Selling & Marketing Expenses | 172.01M | 153.04M | 145M | 111.02M | 118.68M | 129.66M | 107.11M | 94.8M | 89.22M | 77.73M | 65.01M | 41.55M | 30.33M | n/a | n/a | n/a | n/a |
| Cost & Expenses | 774.34M | 587.3M | 595.9M | 408.7M | 378.13M | 385.32M | 319.8M | 306.7M | 308.39M | 239.54M | 202.83M | 138.84M | 88.38M | 51.77M | 36.93M | 43.55M | 59.29M |
| Income Tax | 36.45M | 19.75M | -2.61M | 14.42M | -125.43M | 268K | 46K | 140K | 105K | 264K | 173K | -442K | -3.95M | 7.25M | 4.78M | 3.16M | -3.5M |
| Shares Outstanding (Basic) | 46.24M | 46.22M | 45.52M | 44.26M | 42.67M | 41.51M | 40.91M | 39.81M | 37.2M | 36.54M | 35.17M | 33.11M | 30.33M | 16.44M | 17.23M | 573.12K | 528.36K |
| Shares Outstanding (Diluted) | 46.24M | 51.98M | 46.54M | 45.63M | 43.68M | 41.51M | 40.91M | 39.81M | 37.24M | 41.3M | 35.3M | 33.18M | 30.33M | 16.44M | 17.23M | 573.12K | 528.36K |
| EPS (Basic) | -2.15 | 0.91 | 0.35 | 0.95 | 3.41 | -0.27 | -0.01 | -1.07 | -1.02 | 0.05 | -0.39 | -1.93 | -1.72 | -2.64 | -1.58 | -55.32 | -79.23 |
| EPS (Diluted) | -2.15 | 0.81 | 0.34 | 0.92 | 3.33 | -0.27 | -0.01 | -1.07 | -1.02 | 0.04 | -0.39 | -1.93 | -1.72 | -2.64 | -1.58 | -55.32 | -79.23 |
| EBITDA | 29.12M | 157.58M | 144.78M | 118.47M | 71.42M | 55.29M | 33.05M | -10.59M | -17.86M | 21.39M | 5.09M | -50.73M | -44.55M | -34.23M | -19.12M | -24.12M | -41.53M |
| Depreciation & Amortization | 78.78M | 75.57M | 91.5M | 28.55M | 19.91M | 19.58M | 13.16M | 13.83M | 12.92M | 11.47M | 10.04M | 5.75M | 5.65M | 4.31M | 4.25M | 4.43M | 3.83M |